- PROJECT 1 Cancer cells display uncontrolled inheritance of chromosomes, including errors in DNA replication and mitosis. These errors cause and propagate mutations and chromosomal abnormalities that further enhance cancer. Project 1 has been a leader in studying the mechanisms and control of inheritance of the human genome and has identified many of the key proteins that are involved in DNA synthesis at the replication fork and other proteins that are involved in the initiation of DNA replication. In the proposed studies, Project 1 will continue focusing on the mechanism and regulation of the initiation of DNA replication. Project 1 has discovered that certain initiation proteins are involved in many aspects of the cell division cycle, including centrosome duplication, centromere function and cytokinesis. Recent results also show that some initiation proteins are intimately involved in the fundamental decision of whether newly born cells will commit to a new round of cell division or enter into a period of quiescence. The proposed research will fall into three areas.
Specific Aim 1 will focus on the role of the Origin Recognition Complex (ORC) subunit ORC1 and its related protein CDC6 in regulation of the commitment to cell division by controlling the expression of E2F1-regulated genes, in addition to the gene encoding Cyclin E, in cooperation with the tumor suppressor protein RB and the histone methyltransferase SUV39H1.
Aim 1 will also focus on how CDC6 cooperates with ORC, RB, SUV39H1 and Cyclin dependent kinases to promote initiation of DNA replication.
Specific Aim 2 will continue to study the role of the ORC subunits ORC2 and ORC3 at centromeres. ORC2 interacts with the Spindle Assembly Checkpoint protein BUBR1 only when it is phosphorylated during mitosis and defects in the BUBR1 binding domain of ORC2 cause the persistence of chromosomes that fail to align at the metaphase plate.
Aim 2 will determine how ORC2 binds to BUBR1 and controls access of BUBR1. How ORC2 and ORC3 are recruited to centromeres, and the role of ORC3 interaction with the HP1 heterochromatin protein in chromosome segregation will also be studied. Project 3 will also study E2f1-regulated control of cell proliferation in a subset of breast and colon epithelial cancers have an acquired dependence of the DEAD-box RNA helicase DDX5. DDX5 is also required for progression of Acute Myeloid Leukemia (AML).
This Aim will investigate how DDX5 becomes essential in some adult cancers and AML, while dispensable in normal epithelial and normal hematopoietic cells. Both RNA and protein binding partners will be identified, comparing both DDX5-dependent (DDX5-D) and DDX5-independent (DDX5-I) breast cancer cells. Exploiting the differential dependence on DDX5, Anti-Sense Oligonucleotides (ASO) will be developed for studying the role of DDX5 in mouse models for breast cancer and AML.

Public Health Relevance

- PROJECT 1 Cancer is fundamentally a series of diseases that have in common the uncontrolled proliferation of tumor cells, both locally and at metastatic sites. Project 1 is aimed at understanding how the genome of normal and cancer cells is duplicated and inherited and how these processes are controlled, with the goal of identifying new therapeutic strategies to treat cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA013106-49
Application #
10092122
Study Section
Special Emphasis Panel (ZCA1)
Project Start
1997-02-10
Project End
2023-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
49
Fiscal Year
2021
Total Cost
Indirect Cost
Name
Cold Spring Harbor Laboratory
Department
Type
DUNS #
065968786
City
Cold Spring Harbor
State
NY
Country
United States
Zip Code
11724
Banito, Ana; Li, Xiang; Laporte, Aimée N et al. (2018) The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma. Cancer Cell 34:346-348
Skucha, Anna; Ebner, Jessica; Schmöllerl, Johannes et al. (2018) MLL-fusion-driven leukemia requires SETD2 to safeguard genomic integrity. Nat Commun 9:1983
Banito, Ana; Li, Xiang; Laporte, Aimée N et al. (2018) The SS18-SSX Oncoprotein Hijacks KDM2B-PRC1.1 to Drive Synovial Sarcoma. Cancer Cell 33:527-541.e8
Lin, Kuan-Ting; Ma, Wai Kit; Scharner, Juergen et al. (2018) A human-specific switch of alternatively spliced AFMID isoforms contributes to TP53 mutations and tumor recurrence in hepatocellular carcinoma. Genome Res :
On, Kin Fan; Jaremko, Matt; Stillman, Bruce et al. (2018) A structural view of the initiators for chromosome replication. Curr Opin Struct Biol 53:131-139
Knott, Simon R V; Wagenblast, Elvin; Khan, Showkhin et al. (2018) Asparagine bioavailability governs metastasis in a model of breast cancer. Nature 554:378-381
Shamay, Yosi; Shah, Janki; I??k, Mehtap et al. (2018) Quantitative self-assembly prediction yields targeted nanomedicines. Nat Mater 17:361-368
Tramentozzi, Elisa; Ferraro, Paola; Hossain, Manzar et al. (2018) The dNTP triphosphohydrolase activity of SAMHD1 persists during S-phase when the enzyme is phosphorylated at T592. Cell Cycle 17:1102-1114
Arun, Gayatri; Diermeier, Sarah D; Spector, David L (2018) Therapeutic Targeting of Long Non-Coding RNAs in Cancer. Trends Mol Med 24:257-277
Tarumoto, Yusuke; Lu, Bin; Somerville, Tim D D et al. (2018) LKB1, Salt-Inducible Kinases, and MEF2C Are Linked Dependencies in Acute Myeloid Leukemia. Mol Cell 69:1017-1027.e6

Showing the most recent 10 out of 610 publications